|
Volumn 18, Issue 4, 2006, Pages 371-373
|
Host-pathogen interactions
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BCG VACCINE;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
INFLUENZA VACCINE;
MALARIA VACCINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
AVIAN INFLUENZA;
BIOLOGICAL WARFARE;
CAUSE OF DEATH;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
DISEASE SEVERITY;
EDITORIAL;
HLA SYSTEM;
HOST PATHOGEN INTERACTION;
HOST RESISTANCE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
IMMUNE SYSTEM;
IMMUNOGENETICS;
INFECTION;
INFECTION CONTROL;
INFECTION PREVENTION;
INFLUENZA VIRUS;
INNATE IMMUNITY;
MALARIA;
MORTALITY;
SARS CORONAVIRUS;
SEVERE ACUTE RESPIRATORY SYNDROME;
TRYPANOSOMA CRUZI;
TUBERCULOSIS;
VACCINATION;
ANIMALS;
HOST-PARASITE RELATIONS;
HUMANS;
INFECTION;
|
EID: 33745403176
PISSN: 09527915
EISSN: None
Source Type: Journal
DOI: 10.1016/j.coi.2006.05.009 Document Type: Editorial |
Times cited : (8)
|
References (0)
|